OTC Pharmaceuticals - CIS | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$7.65bn in 2024. The market is expected to grow annually by 3.57% (CAGR 2024-2029).
The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$2.07bn in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$31.51 are generated in 2024.
In the OTC Pharmaceuticals market, 9.5% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in CIS is experiencing significant growth and development due to several key factors. Customer preferences for self-medication and increasing healthcare awareness are driving the demand for over-the-counter (OTC) medicines.

Additionally, local special circumstances and underlying macroeconomic factors play a role in shaping the market trends. Customer preferences in the CIS region are shifting towards self-medication and OTC medicines. Consumers are becoming more proactive in managing their health and are seeking convenient and accessible options for treating common ailments.

This preference for self-care is driving the demand for OTC pharmaceuticals, as they offer a wide range of products that can be purchased without a prescription. Furthermore, the increasing healthcare awareness among consumers is also contributing to the growth of the OTC Pharmaceuticals market. As people become more educated about their health and well-being, they are more inclined to seek out OTC medicines for minor illnesses and preventive care.

The trends in the OTC Pharmaceuticals market in the CIS region are influenced by global and regional market dynamics. There is a growing trend towards the use of herbal and natural remedies, as consumers are becoming more conscious of the potential side effects of synthetic drugs. This has led to an increase in the demand for herbal and natural OTC medicines.

Additionally, the rise of e-commerce and online retail channels has made it easier for consumers to access OTC pharmaceuticals, further fueling market growth. Local special circumstances also play a role in shaping the OTC Pharmaceuticals market in the CIS region. The region has a large population and a growing middle class, which is driving the demand for affordable healthcare solutions.

OTC medicines provide a cost-effective alternative to prescription drugs, making them a popular choice among consumers. Furthermore, the CIS region has a well-established pharmaceutical industry, with several local manufacturers producing a wide range of OTC medicines. This local production capability ensures a steady supply of OTC pharmaceuticals and contributes to the growth of the market.

Underlying macroeconomic factors also contribute to the development of the OTC Pharmaceuticals market in the CIS region. Economic growth, increasing disposable incomes, and improving healthcare infrastructure are creating favorable conditions for market expansion. As the economy improves, consumers have more purchasing power, which allows them to invest in their health and well-being.

Additionally, the improving healthcare infrastructure provides better access to healthcare services, including OTC medicines. In conclusion, the OTC Pharmaceuticals market in the CIS region is experiencing growth and development due to customer preferences for self-medication, increasing healthcare awareness, local special circumstances, and underlying macroeconomic factors. The shift towards self-care, the demand for herbal and natural remedies, and the rise of e-commerce are driving market trends.

The large population, growing middle class, and well-established pharmaceutical industry in the CIS region contribute to the market's growth. Furthermore, economic growth, increasing disposable incomes, and improving healthcare infrastructure create favorable conditions for market expansion.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.